Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an update.
WuXi AppTec Co., Ltd. has announced that its board of directors will convene on October 24, 2025, to review and approve the company’s third-quarter financial results for the period ending September 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical and biotechnology industry. The company, along with its subsidiaries, focuses on providing comprehensive laboratory and manufacturing services to support the pharmaceutical, biotech, and medical device industries globally.
Average Trading Volume: 9,387,392
Technical Sentiment Signal: Buy
Current Market Cap: HK$354.3B
For detailed information about 2359 stock, go to TipRanks’ Stock Analysis page.